Notably, the Tf-ELE/CTX@BLIP group showed the smallest glioma size, and the necrosis area was approximately 3/4 of the total tumor area, indicating that the active-targeting biomimetic nanoplatform exhibited the highest anti-glioma effect compared with the other treatments. The gene discussed is TF; the disease is central nervous system cancer.